AN INDIAN was fully justified to reject a patent bid by Swiss drug giant Novartis last week, India’s trade and industry minister insisted in Geneva on Monday (April 8), defending the country’s generic drug business. “The reasons for the denial are absolutely justified under the law,” Anand Sharma told…
To continue reading this article log in to your GG2 account. Or register now, it's free.
